Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Biomarkers in CAA
NCT03969732Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2018
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by National Taiwan University Hospital. Primary endpoint: Positron Emission Tomography Imaging at 3 days. Status: unknown.
Beyond the preview
Go deeper on NCT03969732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03969732.